JEFFS ROGER

Director at UNITED THERAPEUTICS Corp · on record since Jan 23, 2006
Director at Liquidia Corp · on record since Apr 13, 2026
Chief Executive Officer at Liquidia Corp · on record since Apr 13, 2026
Director at Dova Pharmaceuticals Inc. · on record since Jun 28, 2017
Director at Axsome Therapeutics, Inc. · on record since Jun 9, 2026
Former President and Co-CEO at UNITED THERAPEUTICS Corp · on record since Jun 27, 2016
Director at SANGAMO THERAPEUTICS, INC · on record since Jun 29, 2017
Director at ALBIREO PHARMA, INC. · on record since Sep 29, 2017
Director at Sio Gene Therapies Inc. · on record since Feb 15, 2018
President & COO at UNITED THERAPEUTICS Corp · on record since Nov 18, 2005

Insider trading activity of JEFFS ROGER

Transactions on record: 1,323; since Aug 18, 2003

Open-market buys: 10; $2.6M

Open-market sells: 347; $227.5M

Companies traded: 7; last filing Jul 14, 2026

Figures computed from official regulatory filings — .

Companies where JEFFS ROGER has traded

Liquidia Corp82 tx · $44M · Jul 14, 2026
Axsome Therapeutics, Inc.62 tx · $17.7M · Jun 11, 2026
ALBIREO PHARMA, INC.6 tx · Jun 28, 2021
Dova Pharmaceuticals Inc.10 tx · $739K · Nov 12, 2019
Sio Gene Therapies Inc.2 tx · Apr 17, 2019
SANGAMO THERAPEUTICS, INC4 tx · $100.5K · Sep 7, 2018
1157 tx · $345.5M · Mar 15, 2016

Track record of JEFFS ROGER

Statistical track record

Free

Open-market buys: 10

Last buy: Dec 14, 2023

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of JEFFS ROGER

Co-insiders of JEFFS ROGER

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Liquidia CorpListing unverified	Jul 14, 2026	Exercise	14,333	—	—	SEC
Liquidia CorpListing unverified	Jul 14, 2026	ExerciseD (derivative)	-14,333	0.00 USD	—	SEC
Liquidia CorpListing unverified	Jul 14, 2026	Exercise	13,834	—	—	SEC
Liquidia CorpListing unverified	Jul 14, 2026	Sell	-32,744	71.52 USD	$2.3M	SEC
Liquidia CorpListing unverified	Jul 14, 2026	ExerciseD (derivative)	-13,834	0.00 USD	—	SEC
Liquidia CorpListing unverified	Jul 14, 2026	Sell	-2,505	71.39 USD	$178.8K	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 11, 2026	Sell	-286	246.18 USD	$70.4K	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 11, 2026	Sell	-286	249.12 USD	$71.2K	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 10, 2026	Exercise	1,429	—	—	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 10, 2026	ExerciseD (derivative)	-1,429	0.00 USD	—	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 9, 2026	AwardD (derivative)	1,721	0.00 USD	—	SEC
Liquidia CorpListing unverified	May 28, 2026	Sell	-6,428	62.18 USD	$399.7K	SEC
Liquidia CorpListing unverified	May 26, 2026	Sell	-25,000	61.52 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 26, 2026	Sell	-25,000	60.38 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 26, 2026	Sell	-25,000	61.13 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 20, 2026	Sell	-25,000	56.77 USD	$1.4M	SEC
Liquidia CorpListing unverified	May 20, 2026	Sell	-25,000	58.65 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 20, 2026	Sell	-25,000	61.30 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 15, 2026	Sell	-25,000	58.62 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 15, 2026	Sell	-25,000	57.04 USD	$1.4M	SEC
Liquidia CorpListing unverified	May 15, 2026	Sell	-25,000	56.29 USD	$1.4M	SEC
Liquidia CorpListing unverified	May 12, 2026	Sell	-25,000	54.04 USD	$1.4M	SEC
Liquidia CorpListing unverified	May 12, 2026	Sell	-25,000	42.14 USD	$1.1M	SEC
Liquidia CorpListing unverified	May 12, 2026	Sell	-25,000	41.50 USD	$1M	SEC
Liquidia CorpListing unverified	May 7, 2026	Sell	-25,000	42.09 USD	$1.1M	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Liquidia CorpListing unverified	Jul 14, 2026	Exercise	14,333	—	—	SEC
Liquidia CorpListing unverified	Jul 14, 2026	ExerciseD (derivative)	-14,333	0.00 USD	—	SEC
Liquidia CorpListing unverified	Jul 14, 2026	Exercise	13,834	—	—	SEC
Liquidia CorpListing unverified	Jul 14, 2026	Sell	-32,744	71.52 USD	$2.3M	SEC
Liquidia CorpListing unverified	Jul 14, 2026	ExerciseD (derivative)	-13,834	0.00 USD	—	SEC
Liquidia CorpListing unverified	Jul 14, 2026	Sell	-2,505	71.39 USD	$178.8K	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 11, 2026	Sell	-286	246.18 USD	$70.4K	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 11, 2026	Sell	-286	249.12 USD	$71.2K	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 10, 2026	Exercise	1,429	—	—	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 10, 2026	ExerciseD (derivative)	-1,429	0.00 USD	—	SEC
Axsome Therapeutics, Inc.Listing on record	Jun 9, 2026	AwardD (derivative)	1,721	0.00 USD	—	SEC
Liquidia CorpListing unverified	May 28, 2026	Sell	-6,428	62.18 USD	$399.7K	SEC
Liquidia CorpListing unverified	May 26, 2026	Sell	-25,000	61.52 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 26, 2026	Sell	-25,000	60.38 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 26, 2026	Sell	-25,000	61.13 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 20, 2026	Sell	-25,000	56.77 USD	$1.4M	SEC
Liquidia CorpListing unverified	May 20, 2026	Sell	-25,000	58.65 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 20, 2026	Sell	-25,000	61.30 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 15, 2026	Sell	-25,000	58.62 USD	$1.5M	SEC
Liquidia CorpListing unverified	May 15, 2026	Sell	-25,000	57.04 USD	$1.4M	SEC
Liquidia CorpListing unverified	May 15, 2026	Sell	-25,000	56.29 USD	$1.4M	SEC
Liquidia CorpListing unverified	May 12, 2026	Sell	-25,000	54.04 USD	$1.4M	SEC
Liquidia CorpListing unverified	May 12, 2026	Sell	-25,000	42.14 USD	$1.1M	SEC
Liquidia CorpListing unverified	May 12, 2026	Sell	-25,000	41.50 USD	$1M	SEC
Liquidia CorpListing unverified	May 7, 2026	Sell	-25,000	42.09 USD	$1.1M	SEC